Introduction {#sec1}
============

Healthcare-associated infections (HCAIs) are problematic worldwide, with a recent report by the World Health Organization estimating hospital-wide prevalence in high-income countries at 8%.[@bib1] In addition to causing significant, yet preventable, morbidity and mortality[@bib2] in countries with centrally-funded and managed healthcare systems, such as the UK National Health Service, HCAIs increase waiting times and reduce availability of resources to provide care to the population.[@bib3]

HCAIs present a unique challenge as active transmissions are often only identified after numerous patients have been infected. Additionally, the wide range of HCAI facilitators (e.g. procedures,[@bib4] environment[@bib5]) and increasingly susceptible patients[@bib6] complicate transmission dynamics, making prospective identification and control exceedingly difficult. When multiple cases of an infection occur within a hospital, it is difficult to differentiate a true nosocomial transmission from unrelated cases, and cohorting patients by risk group may lead to assumptions of a common source but molecular analyses often demonstrate lack of transmission.[@bib7]

Sophisticated spatiotemporal analyses can be used to confirm clustering statistically over time and/or space, which would increase confidence in assuming the relatedness of cases. These methods can also be used to control for the effects of cohorting and other patient characteristics that may give the spurious impression of clustering or transmission when it has not occurred. This, in turn, would provide better information on where interventions could be targeted most effectively, and when or where to anticipate outbreaks. These methods may also be useful in more rapid identification of a problem, as even small clusters (e.g. two or three cases) can be detected. Even the introduction of more simplified analytical methods to evaluate spatial and temporal relationships could be beneficial. One example is the Knox test, which has been used widely to detect time--space clusters since the 1960s. The null hypothesis in Knox testing would be that all HCAI cases are independent, and the test returns the number of pairs of cases that are deemed to cluster in time and/or space. The tool is simple to apply as it only requires information on cases, not controls or susceptible individuals, and can work on a minimal clinical dataset.[@bib8]

Nowadays, researchers are using geographic information systems (GIS) to further extend understanding of spatiotemporal clustering and transmission. These are computer-based programs that combine cartography, statistical analysis and database technology to layer databases on top of a predefined map. They have been applied in a range of ecological investigations of disease,[@bib9] and to determine whether there is a spatial association between disease risk and environmental pollution. In this study, GIS and spatial analysis were employed to investigate the risk of breast and lung cancer in a small region.[@bib10] After identification of significant clusters, it was possible to identify local risk factors specific to each cancer type, providing evidence of potential environmental contamination. The use of similar techniques to create hospital maps, on which infection data can be displayed and analysed, could increase understanding of local transmission and risk,[@bib11] and provide rapid dissemination of information through visualization.[@bib12]

With healthcare systems worldwide under pressure to improve patient safety whilst cutting costs, use of the existing infrastructure of routinely collected data, which are often overlooked for HCAI investigation and research,[@bib13] is an innovative solution. Frequently, investigations of HCAIs provide a basic epidemiological description of cases over time by providing an epidemic curve, or show how cases are distributed across wards using a diagram. However, hospital databases contain laboratory results, building management data and floor plans, and information on patient admissions and movement that could easily be incorporated into more detailed analyses to improve understanding of local HCAI epidemiology. Use of interdisciplinary tools may increase the ability to identify transmission prospectively and implement preventive measures.[@bib14]

The aims of this review were to determine the extent of use of spatiotemporal analyses for identifying and preventing HCAI transmission, and to provide recommendations for expanding the use of GIS and spatiotemporal statistical analyses within healthcare settings.

Methods {#sec2}
=======

A systematic review of the literature on spatiotemporal examination of infectious diseases in healthcare settings between January 1961 and June 2013 was conducted using the following search terms: infection (e.g. HCAI, nosocomial, etc.); healthcare settings (e.g. hospital, intensive care, etc.); and time/space (e.g. space--time, spatial epidemiology, etc.). Potential synonyms for each search term (e.g. infection, healthcare settings and time/space) were identified and combined using Boolean operators.

To ensure comprehensive capture of the literature, BIOSIS, Cochrane Review, CSA, DARE, Embase, HEED, JSTOR, PubMed, Science Direct and Web of Science were searched for all indexed publications. Additionally, Google Scholar was searched for indexed and grey literature using the above search terms. All papers, reports, abstracts and letters were included in the initial search.

Inclusion/exclusion criteria {#sec2.1}
----------------------------

Inclusion/exclusion was conducted in two stages: abstract/title review and full-text review. All identified titles/abstracts were reviewed independently by two authors to ensure reliability in full-text retrieval. Papers were retrieved if they mentioned time or space in the abstract, or no abstract was provided and the title did not provide enough information to assess inclusion.

Full-text papers were reviewed independently by two authors and included if they were: (a) published post-1961; (b) written in English; (c) examined potential transmission in more than three patients; (d) provided more than a simple report of cases over time periods exceeding three months (i.e. not routine national surveillance reports); and (e) discussed time/space as a specific aim or discussion point of the study, rather than a simple mention in the results. Any studies on which the reviewers did not agree were discussed and a consensus was reached.

Data extraction {#sec2.2}
---------------

The methodologies of all included studies were reviewed and categorized into either descriptive or analytical studies of time/space, and further 'subtyped' based on the data and analyses employed. Studies were classified as 'case reporting' if they only used temporal or spatial data as an overview (i.e. an epidemic curve). 'Basic descriptive epidemiology' studies examined how the cases were linked by describing their locality in time and/or space and possible exposure events, but did not use statistical methods to determine the probability that they were linked. 'Basic descriptive epidemiology with molecular data' studies focused on the genetic diversity of the organisms, including a description of the distribution of the strains in space and/or time. 'Statistical spatiotemporal analysis' studies used statistical methods to explore HCAI distribution in time or space. Studies were classified as 'statistical spatiotemporal analysis with molecular data' if they combined molecular data with statistical analyses to investigate the dissemination of strains across time or space. The final category, 'spatiotemporal analysis using GIS', included studies that used GIS within hospital settings. Findings were synthesized to evaluate the actual use of spatiotemporal analysis on infectious diseases in healthcare settings. Meta-analysis was considered but was not deemed to be feasible due to the heterogeneity of research designs and outcome measures; as such, the findings were synthesized qualitatively.

Results {#sec3}
=======

In total, 43,819 titles/abstracts were identified during the literature search ([Figure 1](#fig1){ref-type="fig"} ). Of these, 584 met the inclusion criteria for full-text retrieval. Four of the included studies were not available, and 146 were included in the review. Most of the studies excluded did not meet the spatiotemporal criteria; 171 provided some spatiotemporal results but did not discuss this information as it was not the focus of the study. Others examined annual trends, were case studies or review papers, or focused on non-healthcare settings. Six studies were excluded for being written in a language other than English.Figure 1Flowchart of article inclusion.

Characteristics of included studies {#sec3.1}
-----------------------------------

Included studies were predominantly descriptive in their reporting of spatiotemporal data (85%), and varied greatly in encompassing a range of settings, populations and HCAIs. Half of the studies were carried out hospital-wide (53%), 42% (*N* = 61) were performed on specific wards, and only seven (5%) were based within nursing homes. The majority of studies were retrospective (72%), often using data to investigate outbreaks after the event had ended. Five (3%) studies combined retrospective analyses and prospective interventions to enhance surveillance, whilst the remaining 25% of studies were prospective.

Numerous HCAIs were investigated, with the most common group being bacteria (62%), such as meticillin-resistant *Staphylococcus aureus* (MRSA) (11%) and *Clostridium difficile* (10%). Studies focusing solely on viral or fungal infections accounted for 29% of studies, including norovirus (3%), severe acute respiratory syndrome (3%) and *Aspergillus* spp. (7%). Among the 74 molecular studies in this review, only five incorporated spatiotemporal analyses to understand the transmission dynamics.

The studies were separated into two types, 'descriptive' and 'analytical', based on their use of spatiotemporal-specific statistical analyses. To enable clearer comparisons between the groups and to evaluate the variation in exploitation of clinical data, the studies were further classified into six subtypes ([Table I](#tbl1){ref-type="table"} ). These are described in detail below.Table ICategories of studies identified in the reviewStudy typeStudy subtypeNumber of papers (%)Descriptive (*N* = 124, 85%)Case reporting29 (20)Basic descriptive epidemiology26 (18)Basic descriptive epidemiology with molecular data69 (47)Analytical (*N* = 22, 15%)Statistical spatiotemporal analysis13 (9)Statistical spatiotemporal analysis with molecular data5 (3)Spatiotemporal analysis using geographic information systems4 (3)

Descriptive studies {#sec3.2}
-------------------

Descriptive studies primarily focused on summarizing outbreak investigations, environmental assessments and cluster identification. For the vast majority of these studies, causes or sources of outbreaks, cases or clustering were the primary aim. However, simple qualitative descriptions were not sufficient in most cases to confirm or refute identified sources or clusters.

### Case reporting studies {#sec3.2.1}

Basic descriptions of time and space were common (20%, *N* = 29) ([Table II](#tbl2){ref-type="table"} ). Two-thirds of these studies provided a retrospective temporal description of the incidence of cases over time (i.e. an epidemic curve). Many of these studies examined outbreaks[@bib15], [@bib16], [@bib17], [@bib18], [@bib19], [@bib20], [@bib21], [@bib22] and evaluations of intervention strategies,[@bib23], [@bib24], [@bib25] while others attempted to identify factors associated with potential nosocomial transmission (i.e. healthcare worker carriage,[@bib26], [@bib27] direct contact with cases,[@bib28], [@bib29] inadequate cleaning of medical equipment[@bib30], [@bib31] and the physical layout of hospital utilities[@bib32], [@bib33]). Only four studies described the spatial distribution of cases to show the impact of hospital renovations[@bib34] or the layout of cases across specialities,[@bib16], [@bib27], [@bib34], [@bib35] with the majority of studies describing temporal trends in cases.[@bib36], [@bib37] Most case reporting studies examined bacteria (62%); however, the most informative studies were those examining organisms such as *Aspergillus* spp. and *Legionella* spp., where environmental contamination is considered to be the primary risk factor.[@bib15], [@bib35], [@bib38], [@bib39], [@bib40], [@bib41], [@bib42] Table IICharacteristics of descriptive studies included in the review (*N* = 124)Temporal/spatial focusFirst authorYearSettingOrganismMolecular methodsAimStudy designCase reportingSArnow PM1978Renal ward*Aspergillus* spp.N/ADescribe outbreakRetrospectiveSBaird SF2011Haematology wardNon-tuberculous mycobacteriumN/AOutbreak investigationRetrospectiveSPanwalker AP1986Whole hospital*Mycobacterium gordonae*N/ADescribe IC measuresRetrospectiveSPatterson JE1998Geriatric wardHibN/ADetect clustersRetrospectiveTAddiss DG1991Nursing home*Bordetella pertussis*N/ADescribe outbreakRetrospectiveTAlonso-Echanove J2001Whole hospital*Mycobacterium tuberculosis*N/ADescribe outbreakRetrospectiveTArnow PM1991Whole hospital*Aspergillus* spp.N/AAssess environmental contaminationProspectiveTArnow PM1998Haematology wardBloodstream infectionN/ADescribe outbreakRetrospectiveTArnow PM1982Whole hospital*Legionella pneumophila*N/ADescribe outbreakRetrospectiveTBayat A2003Intensive care unitMultipleN/ADescribe outbreakRetrospectiveTBelani A1986Paediatric ward*Staphylococcus aureus*N/ADescribe outbreakRetrospectiveTBonilla HF1997Whole hospitalVREN/ADescribe incidenceProspectiveTCartmill TDI1994Haematology ward*Clostridium difficile*N/ADescribe impact of IC measuresProspectiveTEmont SL1993Nursing homeGastroenteritisN/ADescribe incidenceRetrospectiveTFourneret-Vivier A2006Whole hospital*Aspergillus* spp.N/ADescribe incidenceProspectiveTFowler SL1998Paediatric ward*Candida lusitaniae*N/ADescribe transmissionRetrospectiveTHaley CE1979Whole hospital*Legionella pneumophila*N/AOutbreak investigationBothTKlimowski LL1989Whole hospital*Aspergillus* spp.N/ADescribe incidenceRetrospectiveTLai KK1998Whole hospitalVREN/AAssess impact of IC measuresProspectiveTLarson JL2003Whole hospital*Mycobacterium tuberculosis*N/AOutbreak investigationRetrospectiveTOfner-Agostini M2006Multiple hospitalsSARSN/AReview IC policiesRetrospectiveTPegues CF2001Whole hospital*Aspergillus* spp.N/ADescribe incidenceRetrospectiveT and SAbulrahi HA1997Whole hospital*Plasmodium falciparum*N/ADetermine transmission routeProspectiveT and SDavies BI1999Whole hospital*Streptococcus pyogenes*N/AOutbreak investigationRetrospectiveT and SDeutscher M2011Whole hospitalGroup A streptococcusN/AIdentify risk factorsRetrospectiveT and SHelms CM1983Whole hospital*Legionella pneumophila*N/AOutbreak investigationRetrospectiveT and SMacDonald KS1993Whole hospital*Clostridium difficile*N/ADescribe incidenceRetrospectiveT and SMcGrathEJ2011Paediatric ward*Acinetobacter* spp.N/ADetermine transmission routeRetrospectiveT and SWangH2013Whole hospital*Listeria monocytogenes*N/ADescribe clinical outcomesRetrospective  Basic descriptive epidemiologySLentino JR1982Whole hospital*Aspergillus* spp.N/ADetect clustersRetrospectiveTBowen KE1995Whole hospital*Clostridium difficile*N/ADescribe incidenceRetrospectiveTBuchbinder N2011Paediatric wardInfluenza A (H1N1)N/ADescribe impact of IC measuresRetrospectiveTBurney MI1980Whole hospitalCCHFN/AOutbreak investigationRetrospectiveTBurwen DR2001Paediatric ward*Aspergillus* spp.N/AOutbreak investigationRetrospectiveTDegail MA2012Whole hospitalHuman metapneumovirusN/AOutbreak investigationRetrospectiveTFretz R2009Whole hospitalNorovirusN/AOutbreak investigationRetrospectiveTGastmeier P2003Paediatric ward*Klebsiella pneumoniae*N/ADescribe a cluster of casesProspectiveTGomersall CD2006Intensive care unitSARSN/ADescribe incidenceProspectiveTKaplan JE1982Nursing homeNorovirusN/AEvaluate transmissionRetrospectiveTKimura AC2005Paediatric ward*Ralstonia pickettii*N/AOutbreak investigationRetrospectiveT and SAlam NK2005Whole hospital*Salmonella enterica*N/ADescribe clusterRetrospectiveT and SAuerbach SB1992Nursing homeGroup A streptococcusN/AOutbreak investigationRetrospectiveT and SBarrett SP1988Whole hospitalMRSAN/ADescribe incidenceRetrospectiveT and SBitar CM1987Whole hospitalMRSAN/ADescribe outbreakRetrospectiveT and SChen YC2004A&ESARSN/AOutbreak investigationRetrospectiveT and SFaustini A2004Whole hospitalNecrotizing enterocolitisN/AOutbreak investigationRetrospectiveT and SFoulke GE1989Intensive care unit*Clostridium difficile*N/ADescribe use of IC measuresRetrospectiveT and SGoldmann DA1981Paediatric wardMultipleN/ADescribe outbreakProspectiveT and SLai KK2001Transplant ward*Aspergillus* spp.N/ADetect clustersRetrospectiveT and SMody LR2001Whole hospital*Clostridium difficile*N/ADescribe incidenceProspectiveT and SPavlov I2009Whole hospital*Clostridium difficile*N/ADetect clustersRetrospectiveT and SPegues DA1993Nursing homeGastroenteritisN/AOutbreak investigationRetrospectiveT and SStrabelli TMV2006Paediatric ward*Enterococcus faecalis*N/ADetect clustersRetrospectiveT and STurcios-Ruiz RM2008Paediatric wardNorovirusN/AOutbreak investigationRetrospectiveT and SWarren D1989Whole hospitalKeratoconjunctivitisN/AOutbreak investigationRetrospective  Basic descriptive epidemiology with molecular dataSAbdallah IM2006Whole hospitalMultipleRAPDInvestigate strain distributionRetrospectiveSAita J1996Whole hospital*Mycobacterium tuberculosis*RFLPOutbreak investigationRetrospectiveSHoefnagels-Schuerman A1997Whole hospitalMRSAPFGEOutbreak investigationProspectiveSKatsoulidou A1999Haematology wardHepatitis C virusPCROutbreak investigationRetrospectiveSPegues DA2002Intensive care unit*Aspergillus* spp.RFLPDetect clustersRetrospectiveSVazquez JA1993Whole hospital*Candida albicans*REAInvestigate strain distributionProspectiveSVenezia RA1994Intensive care unit*Legionella pneumophila*PFGEIdentify sourceRetrospectiveSWitte W2001Multiple hospitalsMRSAPCRInvestigate strain distributionProspectiveSZervos MJ1987Whole hospital*Enterococcus faecalis*Plasmid typingDescribe incidenceProspectiveTAdachi JA2009Intensive care unit*Pseudomonas aeruginosa*PFGEAssess impact of molecular typingRetrospectiveTAdams G1981Paediatric wardHerpes simplex virus 1REFDescribe outbreakRetrospectiveTAlfieri N1999Intensive care unit*Stenotrophomonas maltophilia*RFLPOutbreak investigationBothTAllander T1995Haematology wardHepatitis C virusPCR/NASeqDetect clustersRetrospectiveTAssadian O2002Paediatric ward*Serratia marcescens*PCRDescribe outbreakRetrospectiveTAumeran C2008Whole hospitalVREPFGEDescribe use of IC measuresProspectiveTBaddour LM1999Whole hospital*Enterococcus faecium*CHEFDescribe outbreakRetrospectiveTBelmares J2009Whole hospital*Clostridium difficile*READescribe incidenceRetrospectiveTBen Abdeljelil J2011Paediatric ward*Candida albicans*PFGEInvestigate strain distributionRetrospectiveTBen Abdeljelil J2012Paediatric ward*Candida albicans*PFGEOutbreak investigationRetrospectiveTBrillowska-Dabrowska A2009Haematology ward*Candida parapsilosis*RAPDAssess impact of molecular typingRetrospectiveTDavinRegli A1996Intensive care unit*Enterobacter aerogenes*RAPDOutbreak investigationProspectiveTEyre DW2012Multiple hospitals*Clostridium difficile*/MRSASNV analysisOutbreak investigationRetrospectiveTFalk PS2000Burns wardVREPFGEOutbreak investigationRetrospectiveTGeis S2013Haematology wardRespiratory syncytial virusRT-PCROutbreak investigationRetrospectiveTGray J2012Paediatric ward*Klebsiella pneumoniae*PFGEDetect clustersRetrospectiveTHarvala H2012Haematology wardParainfluenza type 3RT-PCROutbreak investigationRetrospectiveTHelali NE2005Whole hospital*Staphylococcus aureus*PFGEOutbreak investigationBothTHelweg-Larsen J1998Whole hospital*Pneumocystis carinii*PCRDetect clustersRetrospectiveTHong KB2012Paediatric ward*Acinetobacter baumannii*MLSTOutbreak investigationRetrospectiveTKakis A2002Whole hospitalGroup A streptococcusM typing/T agglutinationOutbreak investigationRetrospectiveTLayton MC1993Dermatology wardMRSAPFGEDetect clustersRetrospectiveTL\'Ecuyer PB1996Multiple hospitals*Salmonella senftenberg*PFGEOutbreak investigationRetrospectiveTLe Gal S2012Renal ward*Pneumocystis* spp.RFLPDetect clustersRetrospectiveTLoudon KW1994Haematology ward*Aspergillus fumigatus*RAPDDetect clustersRetrospectiveTMcAdams RM2008Paediatric wardMRSAPFGEDetect clustersRetrospectiveTMcFarland LV1989Whole hospital*Clostridium difficile*ImmunoblotDescribe incidenceProspectiveTPeta M2006Intensive care unit*Enterococcus faecium*PFGEOutbreak investigationBothTRupp ME2001Paediatric wardVREPFGEOutbreak investigationProspectiveTSardan YC2004Whole hospital*Klebsiella oxytoca*AP-PCROutbreak investigationRetrospectiveTZoltanski J2011Paediatric wardARGNBPFGEDescribe incidenceProspectiveT and SAbb J2004Whole hospitalMRSAPFGEInvestigate strain distributionProspectiveT and SAbbo A2005Whole hospital*Acinetobacter baumannii*PFGEDescribe incidenceRetrospectiveT and SArnold KE2006Nursing homeGroup A streptococcusRFLPOutbreak investigationRetrospectiveT and SBoyce JM1993Whole hospitalMRSAPlasmid typingAssess impact of IC measuresRetrospectiveT and SByers KE2001Whole hospitalVREPFGEAssess impact of IC measuresProspectiveT and SCarneiro MAS2007Haematology wardHepatitis C virusRT-PCRInvestigate strain distributionProspectiveT and SChen LF2011Haematology wardInfluenza A (H1N1)RT-PCROutbreak investigationRetrospectiveT and SCulebras E2010Whole hospital*Acinetobacter baumannii*RAPDDescribe outbreakRetrospectiveT and SCuny C1993Whole hospitalMRSAPhage typingOutbreak investigationRetrospectiveT and SDebast SB1996Intensive care unit*Acinetobacter baumannii*PCR fingerprintingOutbreak investigationRetrospectiveT and SDiab-Elschahawi M2012Intensive care unit*Candida parapsilosis*Microsatellite typing/repPCROutbreak investigationProspectiveT and SDijkshoorn L1993Intensive care unit*Acinetobacter* spp.DNA-DNA hybridizationInvestigate strain distributionRetrospectiveT and SEnglund JA1991Whole hospitalRespiratory syncytial virusEIAEvaluate possible transmissionProspectiveT and SFawley WN2001Whole hospital*Clostridium difficile*RAPDInvestigate strain distributionProspectiveT and SFerroni A1998Whole hospital*Pseudomonas aeruginosa*PFGEOutbreak investigationRetrospectiveT and SFisher GM1986Whole hospitalMultiplePlasmid typingInvestigate strain distributionRetrospectiveT and SGraindorge A2010Intensive care unit*Burkholderia cenocepacia*RFLPDescribe outbreakRetrospectiveT and SKassis C2011Whole hospitalMRSAPFGEOutbreak investigationRetrospectiveT and SKondili LA2006Renal wardHepatitis B/hepatitis CPCROutbreak investigationRetrospectiveT and SLevidiotou S2002Intensive care unit*Acinetobacter baumannii*RAPDDescribe outbreakRetrospectiveT and SLin YC2007Paediatric wardMRSAPFGEAssess HCW carriageRetrospectiveT and SLowe C2012Intensive care unit*Klebsiella oxytoca*PFGEOutbreak investigationRetrospectiveT and SLutz BD2003Whole hospital*Aspergillus* spp.RAPDDetect clustersRetrospectiveT and SMarx A1999Nursing homeGastroenteritisRT-PCRDetermine transmission routeRetrospectiveT and SMorter S2011Whole hospitalNorovirusNucleic acid sequencing analysisOutbreak investigationProspectiveT and STraub WH1998Intensive care unit*Pseudomonas aeruginosa*PFGEInvestigate strain distributionProspectiveT and SWidmer AF1993Intensive care unit*Pseudomonas aeruginosa*CHEFEvaluate possible transmissionRetrospectiveT and SXia Y2012Intensive care unit*Acinetobacter baumannii*PCROutbreak investigationRetrospectiveT and SYoon YK2009Paediatric wardVREPFGEAssess impact of IC measuresBoth[^1]

### Basic descriptive epidemiology {#sec3.2.2}

Investigations that described the temporal or spatial distribution of cases were categorized as basic epidemiology (18%, *N* = 26) ([Table II](#tbl2){ref-type="table"}). A number of studies provided a retrospective evaluation of the incidence of cases by assessing temporal links between patients, while 58% of studies combined spatial and temporal elements to varying degrees in their evaluations. The main organisms considered were bacteria (46%); however, the studies that evaluated *Aspergillus* spp. focused on spatial data to the greatest extent. Indeed, the only study that focused solely on the spatial element examined fungal contamination of the hospital environment.[@bib43]

Some studies combined infection information with building 'schematics' to explain the physical layout of the ward[@bib44] or to display the location of patients.[@bib45], [@bib46], [@bib47], [@bib48], [@bib49], [@bib50], [@bib51], [@bib52], [@bib53] However, these studies did not investigate the importance of the geographical distribution of cases, as has been highlighted in studies that have looked at the impact of construction on the incidence of fungal infections.[@bib43], [@bib54], [@bib55], [@bib56] In addition to evaluating the distribution of cases, some investigators used graphics to visualize the connections between cases,[@bib57] and attempted to identify possible clusters[@bib58], [@bib59], [@bib60], [@bib61], [@bib62] or provide evidence of potential transmission.[@bib63], [@bib64]

A number of studies used timelines to evaluate how cases were linked.[@bib65], [@bib66], [@bib67] Chen *et al.* visualized the spread of severe acute respiratory syndrome within an emergency department.[@bib68] By combining temporal data with patient locations, the researchers identified distinct 'clusters' of cases, and prevented further dissemination of the disease by quarantining contacts of these individuals. Whilst the outcome was positive, the assumed clusters were based purely on description of the patients\' locations at certain times, and the lack of statistical analysis meant that the clusters were not proven to be statistically significant.

### Basic descriptive epidemiology with molecular data {#sec3.2.3}

Most descriptive studies incorporated molecular data (47%; *N* = 69) ([Table II](#tbl2){ref-type="table"}), presumably because a molecular link provided more evidence of clustering or transmission than purely describing potential clusters. Numerous studies combined spatiotemporal and molecular data to attempt to develop a better understanding of strain dissemination[@bib69], [@bib70], [@bib71], [@bib72], [@bib73], [@bib74], [@bib75], [@bib76], [@bib77], [@bib78], [@bib79], [@bib80], [@bib81] or potential sources[@bib82], [@bib83], [@bib84], [@bib85] within the institutions in which they were conducted. Integration of molecular and temporal data enabled investigators to highlight potential links between patients, and identify potential transmission events,[@bib86], [@bib87], [@bib88], [@bib89], [@bib90], [@bib91], [@bib92] with greater substantiation than simple descriptive studies. In one study, researchers were able to differentiate between two consecutive outbreaks of *Stenotrophomonas maltophilia* on their intensive care unit by visualizing the temporal distribution of isolates identified using restriction fragment length polymorphism (RFLP)[@bib93]; however, it is possible that these two distinct outbreaks could have encompassed several smaller events with the same RFLP type introduced multiple times.

Descriptive studies that included molecular data covered a range of applications including outbreak investigations,[@bib94], [@bib95], [@bib96], [@bib97], [@bib98], [@bib99], [@bib100], [@bib101], [@bib102] cluster identification[@bib103] and improving control interventions.[@bib104], [@bib105] However, the most common applications of molecular typing were in identifying the probable sources of an infection[@bib106], [@bib107], [@bib108], [@bib109], [@bib110], [@bib111], [@bib112], [@bib113], [@bib114] and whether transmission had occurred.[@bib77], [@bib115], [@bib116], [@bib117], [@bib118], [@bib119], [@bib120], [@bib121] Many studies evaluated the distribution of strains over time or space,[@bib122], [@bib123], [@bib124], [@bib125], [@bib126] aiming to establish epidemiological links between cases, but were limited by lack of statistical analysis. The geographical layout of cases was used in some studies to suggest potential factors associated with their distribution.[@bib127], [@bib128], [@bib129], [@bib130], [@bib131], [@bib132], [@bib133] The study by Witte *et al.* mapped the distribution of MRSA strains at national level in Germany to compare changes in resistance phenotypes with various local prescription practices across regions,[@bib134] but there were no statistical analyses to support or refute these qualitative observations.

Analytical studies {#sec3.3}
------------------

Analytical studies tended to focus more on predictive modelling of future outbreaks and determining the impact of various changes within the healthcare setting, rather than describing an outbreak. They used a wide range of statistical modelling techniques, indicating a number of options for looking at spatiotemporal clustering. Interestingly, a number of the descriptive studies focused on identifying the source of an outbreak, and found that they were unable to do so conclusively. In contrast, GIS was shown to enable fast identification of possible sources during an outbreak, and enabled a targeted investigation that led to the source being discovered. This was possible using clinical data that are collected routinely, and required little additional data retrieval.

### Statistical spatiotemporal analysis {#sec3.3.1}

Thirteen studies (9%) conducted statistical analyses of temporal and spatial data ([Table III](#tbl3){ref-type="table"} ). All were undertaken in hospital settings, 85% (*N* = 11) were published in 2000 or later, and 62% (*N* = 8) focused on bacterial infections.Table IIICharacteristics of analytical studies included in the review (*N* = 22)Temporal/spatial focusFirst authorYearSettingOrganismMolecular methodsStatistical methodsAimStudy designStatistical spatiotemporal analysisTAldeyab MA2009Whole hospital*Clostridium difficile*N/AARIMA time seriesAssess impact of AB useRetrospectiveTAldeyab MA2008Whole hospitalMRSAN/AARIMA time seriesAssess impact of AB useRetrospectiveTBertrand X2012Whole hospitalMRSAN/AARIMA time seriesAssess impact of IC measuresRetrospectiveTBirnbaum D1984Whole hospitalMultipleN/AOutbreak threshold levelsDetect outbreaksProspectiveTCharvat H2010Whole hospitalMultipleN/AMonte Carlo/time interval distance modellingDetect clustersRetrospectiveTHaley RW1982Paediatric ward*Staphylococcus aureus*N/AMulti-variate statistical modelAssess impact of IC measuresRetrospectiveTPolgreen PM2010Multiple hospitals*Clostridium difficile*/influenzaN/AAuto-regressive time series analysisCharacterize incidenceRetrospectiveTVernaz N2008Whole hospital*Clostridium difficile*N/AARIMA time seriesAssess impact of AB useProspectiveT and SKong F2012Whole hospitalMRSAN/ANested tri-level hierarchical log regression modelsQuantify infection riskRetrospectiveT and SKroker P2001Whole hospital*Clostridium difficile*N/AKnox regression analysisDetect clustersRetrospectiveT and SRushton SP2010Intensive care unitMultipleN/AMonte CarloInvestigate spread of infectionRetrospectiveT and SStarr JM2009Whole hospital*Clostridium difficile*N/AMonte Carlo Markov chainAssess impact of IC measuresRetrospectiveT and SYu ITS2005Whole hospitalSARSN/ACox regression analysisOutbreak investigationRetrospective  Statistical spatiotemporal analysis with molecular informationTde Celles MD2012Surgical wardMDRABrepPCRStochastic transmission modelAssess impact of molecular typingRetrospectiveTGandhi NR2013Whole hospitalXDRTBRFLPNetwork analysisInvestigate transmissionRetrospectiveTNübel U2013Paediatric wardMRSASNP analysisBayesian skylinesIdentify risk factorsRetrospectiveT and SKumar VS2006Whole hospitalMDRGNNot statedMonte Carlo/SatScanDetect clustersRetrospectiveT and SRexach, CE2005Whole hospital*Clostridium difficile*AP-PCRKnox regression analysisInvestigate transmissionRetrospective  Spatiotemporal analysis using GISSKistemann, T2000Whole hospital*Salmonella enteritidis*N/AGeographical distributionOutbreak investigationRetrospectiveSKruger, H2002Multiple hospitalsMultipleN/AMapping of resistant isolatesMapping distributionProspectiveT and SKho, A2006Whole hospitalMRSA/VREN/AVisualization of HCW movementIdentify risk factorsProspectiveT and SKwan, MYW2009Whole hospitalMultipleN/AICInvestigate spread of infectionProspective[^2]

The temporal studies (*N* = 8) tended to be retrospective and employed time-series analysis (e.g. weekly aggregated measures plotted over time) to demonstrate if antibiotic prescription had an effect on the incidence of MRSA[@bib135], [@bib136], [@bib137] and *C. difficile,* [@bib138] or if control measures for multiple organisms reduced the incidence.[@bib139] Without the incorporation of temporal analysis into these investigations, the impact of the interventions may have been masked by other factors, such as seasonality. Additionally, temporal analysis was used to examine ways to improve infection control measures,[@bib140], [@bib141] while Haley and Bregman used multi-variate statistical models to assess the temporal associations between infections and overcrowding, providing evidence that handwashing compliance is reduced markedly under these conditions.[@bib142]

Spatiotemporal studies (*N* = 5) typically aimed to model infections retrospectively to investigate outbreaks and to detect clustering.[@bib8], [@bib143] By using modelling techniques, others were able to estimate the potential effect of interventions, beyond which descriptive studies could use the results to advocate their incorporation into standard control measures.

### Statistical spatiotemporal analysis with molecular data {#sec3.3.2}

Only 3% (*N* = 5) of studies combined the use of molecular typing with spatial or temporal analyses ([Table III](#tbl3){ref-type="table"}), which has the benefit of molecular differentiation and statistical evidence in confirming transmission. All of these studies were undertaken in 2005 or later, and analysed the retrospective distribution of bacteria while attempting to establish links between isolates.

The earliest study in this category compared the effectiveness of molecular typing with spatiotemporal analysis.[@bib144] Polymerase chain reaction was used to characterize toxin genes in *C. difficile* isolates, which were mapped to a grid representing each ward, and analysed statistically for clustering by Knox test. This identified a single ward cluster compared with four clusters detected by molecular fingerprinting analysis, leading the investigators to conclude that the Knox test was less effective for identifying nosocomial transmission than molecular fingerprinting. However, most studies have shown that in order to gain the most from available data, spatiotemporal and molecular analyses should be used in combination.

The remaining studies evaluated potential transmission routes or attempted to gain a better understanding of outbreaks. Nuebel *et al.* applied whole-genome sequencing of MRSA in a neonatal intensive care unit[@bib145] to compare accumulated sequence variation in the isolates, and used Bayesian skyline analysis to reveal epidemiological links between patients, healthcare workers and parents. They concluded that integration of epidemiological mapping and genomic data was necessary to understand MRSA transmission. Similarly, Gandhi *et al.* performed a retrospective study to investigate epidemiological links between extensively-drug-resistant tuberculosis patients in South Africa[@bib146] by combining RFLP analysis and social network data to build transmission networks among genotypically similar patients. Their findings showed that the epidemic was highly clonal, and network analysis indicated transmission across a network with high levels of interconnectedness. de Celles *et al.* tried to estimate the variability in transmission between different multi-drug-resistant *Acinetobacter baumannii* clonal groups[@bib147] using data on carriage on a surgical ward. They identified three clonal complexes by performing molecular fingerprinting, and applied stochastic transmission models to estimate transmission rates for each complex. Results suggested that one of the clones had enhanced transmissibility compared with the other two clones, and further explained local epidemic dynamics. Finally, Kumar *et al.* [@bib148] optimized cluster identification by organizing multi-drug-resistant Gram-negative bacteria isolates from admitted patients into co-resistance groups, and using schematics of the ward layouts in a Monte Carlo simulation. They concluded that this was 'a powerful way to quickly identify outbreaks', and early detection is critical with the decreasing number of effective treatment regimens available.

### Spatiotemporal analysis using GIS {#sec3.3.3}

GIS was used in only 3% (*N* = 4) of studies identified in this review, demonstrating its limited uptake in the investigation of HCAIs ([Table III](#tbl3){ref-type="table"}); all of these studies were undertaken in 2000 or later. The studies were conducted hospital-wide, and all but one described a prospective application.

Kistemann *et al.* employed GIS for a retrospective investigation of a salmonella outbreak,[@bib149] the source of which could not be identified by biological testing as food samples had been discarded. By mapping the distribution of cases across the hospital site and using analytical tools in GIS, the researchers identified that the sole link between cases was food delivery from a central kitchen. This led to an investigation of food production and the source was discovered. Kruger and Steffen used GIS to undertake geostatistical analysis of local antibiotic resistance to act as an early warning system for the emergence of drug-resistant strains,[@bib150] enabling doctors to alter their prescription practices. Kho *et al.* developed and implemented GIS software that enabled them to demonstrate inappropriate patient placement and insufficient hand hygiene in 14% of healthcare provider--patient contacts.[@bib151] Kwan *et al.* incorporated GIS successfully in a wide range of hospital-based investigations.[@bib12] Using GIS as the central repository for spatial and temporal data of infectious disease cases, the collected data were queried and analysed to identify disease clusters. The results were then communicated to the appropriate personnel, helping decision makers to target control efforts.

Discussion {#sec4}
==========

This review highlights numerous (*N* = 146) studies focusing on spatiotemporal investigations of infectious diseases within healthcare settings; however, very few of these (*N* = 22) used appropriate statistical methods to confirm transmission or clustering. This suggests that spatiotemporal data are regularly collected in healthcare settings to examine the potential for clustering, but confirmation using statistical analysis is infrequent, which introduces the risk of misinterpretation and hence development of less effective interventions and management of the problem. Of note, most of the published descriptive analyses were also retrospective, and in the absence of further statistical testing, provide little information for future prevention or prediction activities. Similarly, while half of all identified studies included molecular techniques for differentiating clusters, many of these were older techniques used to determine very large differences in bacteria, and are not conclusive. Only 7% of studies that included molecular data also used statistical analyses to provide more quantitative evidence of transmission clusters.

Underuse of data {#sec4.1}
----------------

This review found that while the collection of spatiotemporal data has been integral to HCAI prevention activities for decades, the use of spatiotemporal statistical analysis is relatively new to the study of HCAIs in comparison with infectious diseases occurring within the community.[@bib9] Most of the studies identified in this review used spatial and temporal information to provide a qualitative description of disease occurrence by time/space, and in contrast to those that employed more sophisticated analyses, were limited in the scope of their findings. Naturally, the ways in which spatial or temporal data are used within investigations of HCAIs varied greatly, and presentation depended upon the aim of each study. However, the large amount of data collected was often not used to its full potential, and opportunities to gain a more thorough understanding of the problem were missed.

The ability of descriptive studies to identify any significant influences of infectious disease dynamics is limited. Several studies discussed the significance of the geographical distribution of cases without undertaking any analyses,[@bib48], [@bib64], [@bib68] which is a serious issue as sharing the same geographical space does not prove that transmission has occurred.[@bib19], [@bib133] The smaller the scale at which populations are studied, the greater the possibility that 'clustering' of cases could have occurred due to a confounding factor (e.g. cohorting of high-risk patients). This highlights a missed opportunity to learn more about the spread of organisms within healthcare settings, and to develop more effective intervention strategies based upon transmission dynamics within that particular setting.[@bib83]

Maximizing data usage {#sec4.2}
---------------------

It is extremely important that hospitals are able to understand the local HCAI epidemiology to inform their routine practice, rather than generalizing evidence from other settings. A major stumbling block can be the perception that these analyses may involve active data collection; however, an abundance of existing datasets could be used. Examples of disparity in data usage are the studies by Kroker *et al.* and Mody *et al.*, in which they attempted to identify potential clusters of *C. difficile* within their hospitals.[@bib8], [@bib62] Both studies were published in 2001 and used clinical patient notes and laboratory results for *C. difficile* toxin assays. Mody *et al.* defined a cluster arbitrarily as one or more cases occurring within 21 days of a previous case on the same nursing unit, and used this to identify temporal clusters within their dataset; however, they were unable to suggest potential factors related to the observed pattern. Kroker *et al.* employed the Knox test to identify time--space clusters, which highlighted hospital geography and traffic between wards as significant factors, and enabled them to adapt their infection control procedures.

Incorporation of molecular data into investigations can have a profound impact on the effectiveness of any outbreak response. Recent advances in molecular biology, such as rapid benchtop sequencing, have led to a revolution in the detail that can be gained from clinical samples.[@bib88] While many hospitals only perform basic identification of micro-organisms due to the resources available, this data, when available, can be useful to enhance current investigations. A study by Adams *et al.* in 1981 investigated nosocomial infections on a paediatric intensive care unit, and was able to distinguish that there had been two separate outbreaks involving separate strains of herpes simplex virus type 1.[@bib76] The initial investigation, which had not included molecular data, concluded that all cases belonged to a single outbreak, and thus limited the impact of their initial control measures.

Benefits of incorporating statistical testing {#sec4.3}
---------------------------------------------

Molecular data can be invaluable in ruling out a link between cases; however, as emphasized in the study by Helweg-Larsen *et al.*, clusters of infections can occur for many reasons and are often caused by factors other than nosocomial spread.[@bib7] Therefore, incorporation of true temporal or spatial analysis, to eliminate similarity of micro-organisms by chance, alongside molecular techniques could lead to a better understanding of the true transmission dynamics, as inappropriate assumptions are often made about clustering when based solely on molecular data.

Prior to 2000, only two studies were identified that had performed spatial or temporal analysis; in the last decade, this number has increased to 11. This may be due, in part, to the development of novel statistical methods and further advancement of user-friendly statistical and GIS software; however, the majority of the statistical methods in these studies have been widely employed in other fields since before the 1980s. The increased use of electronic databases in hospitals for storage of medical information has created a rich source of epidemiologically and clinically relevant information, allowing more detailed analyses to be performed.

The major aim of this review was to identify how spatiotemporal analyses have been used previously, and to suggest how they can be employed to benefit practices within healthcare settings. The Knox test is a simple analysis that can be used to identify clustering, and methods using outbreak thresholds are common within infection control reporting. However, the ideal situation is to design control programmes based upon the dynamics and processes observed within the local institution.

As randomized controlled trials can be difficult or costly to undertake in clinical settings, some authors have employed predictive modelling techniques to build their own evidence base. For example, Rushton *et al.* used a statistical approach to investigate clustering and patterns of spread of a number of organisms within an intensive treatment unit.[@bib143] They obtained data from pre-existing datasets including numbers of infected patients, admission details, duration of stay and bed movement, whilst they estimated some additional variables from evaluating nurse--patient contacts. They identified variation in the degree of clustering of different organisms, and tested the impact of potential control interventions in the model. The findings suggest that bed movement and staff--patient contacts have to be controlled, and control strategies may need to be organism-specific.

Recommendations {#sec4.4}
---------------

Spatiotemporal analysis can distil a much greater amount of relevant information from data collected on HCAIs than purely descriptive studies. Analysis is key to furthering understanding of the epidemiology and dynamics of transmission of these organisms. The underuse of spatial and temporal data may be due to the primary focus of studies on retrospective actions in response to an outbreak, and this 'fire-fighting' approach may be propagated by institutional goals. However, new sophisticated techniques allow for greater adaptability to the current challenges in health care, including increased cohorting of at-risk patients, spread of resistance and the corresponding decrease in the number of available effective antimicrobials. A focused approach on development of understanding of HCAI epidemiology is likely to lead to identification of significant risk factors and better prevention.

Molecular typing technology is quickly moving from research to clinical settings, and it is becoming more common for detailed molecular analyses to be undertaken to investigate nosocomial infections. From this review, it is clear that the uptake of statistical analyses is the limiting step in moving towards modern sophisticated analyses of HCAIs. Few healthcare workers have the training to develop statistical models or perform in-depth analyses, and this is where collaboration with academic institutions can be exploited to improve the understanding of local disease dynamics without massively increasing the costs to hospitals. These collaborations would provide rich datasets for researchers to use, while enabling clinicians to employ cutting-edge methodologies that will inform their routine practice.

One possible intermediary step would be to further the use of GIS for HCAI investigations, as it enables a wide range of analyses to be undertaken within one piece of software in which staff could be trained. Whilst the initial implementation may be time and cost intensive,[@bib149] the benefits are clear from the few studies identified in this review. The combination of HCAI datasets from numerous sources in one system and subsequent visualization can enable healthcare workers to incorporate up-to-date infection data into their clinical practice. As hospitals move to combine databases and increase the level of electronic recording, this presents an ideal time to incorporate GIS into these systems and create a fully-integrated hospital information system.

With movement of patients between care structures, differentiation between infection control in primary and secondary care is becoming more difficult. The small number (*N* = 7, 5%) of studies based within nursing homes in this review suggests that less attention has been given to care units outside of hospitals. However, these could act as reservoirs of infections, and regular re-admission of their residents could lead to further hospital transmission. In addition to providing an analytical toolkit for spatial clustering, GIS could improve the understanding of this relationship by enabling healthcare providers to consider the impact of their local community.

The future potential applications in healthcare settings are ever expanding as more sophisticated molecular, statistical and computational techniques become increasingly commonplace. Publication of analytical studies on HCAI in major clinical journals rather than specialized niche journals, as observed in this review, could increase awareness of these techniques and widen their use.

Limitations {#sec4.5}
-----------

In structuring the search strategy for the review, the authors endeavoured to ensure the inclusion of studies from as broad a range as possible. However, due to the great variation in the terminology used across the numerous clinical and scientific fields, it is possible that a few studies were missed. Further, the heterogeneity within the evidence base precluded meta-analysis of the findings. Finally, publication bias cannot be fully avoided in a review.

Conclusion {#sec5}
==========

To truly understand and stem the growing problem of HCAIs worldwide, a multi-disciplinary approach is required. This is dependent on the skills and technology available to those investigating the problem, and is likely to require collaboration between experts. This review suggests that greater integration of spatiotemporal techniques into HCAI investigations could prove invaluable in highlighting previously unobserved patterns of infections, and maximizing the understanding of disease dynamics. Given that infections within a small contained area, such as a hospital, have greater potential for misclassification of clustering, it is necessary to use both molecular techniques and the appropriate spatiotemporal statistical techniques to maximize the accuracy of the study findings. Given the expanding technology of information systems (e.g. electronic medical databases), advancement in molecular and statistical techniques, development of analytical platforms that enable greater access to non-experts and increased interdisciplinary collaboration, the potential for using pre-existing data to prevent future avoidable infections and improve patient safety can become a reality.
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[^1]: S, spatial; T, temporal; N/A, not applicable; Hib, *Haemophilus influenzae* type B; VRE, vancomycin-resistant enterococci; SARS, severe acute respiratory syndrome; CCHF, Crimean--Congo haemorrhagic fever; MRSA, meticillin-resistant *Staphylococcus aureus*; ARGNB, antibiotic-resistant Gram-negative bacteria; RAPD, random amplification of polymorphic DNA; RFLP, restriction fragment length polymorphism; PFGE, pulsed-field gel electrophoresis; AP-PCR, arbitrarily primed polymerase chain reaction; repPCR, repetitive element palindromic polymerase chain reaction; CHEF, clamped homogeneous electric field electrophoresis; EIA, enzyme immunoassay; MLST, multi-locus sequence typing; PCR, polymerase chain reaction; REA, restriction endonuclease analysis; REF, restriction endonuclease fingerprinting; RT-PCR, reverse transcriptase polymerase chain reaction; A&E, accident and emergency; HCW, healthcare worker; IC, infection control; NASeq, nucleic acid sequencing analysis; SNV, single nucleotide variant analysis.

[^2]: T, temporal; S, spatial; N/A, not applicable; MRSA, meticillin-resistant *Staphylococcus aureus*; BSI, bloodstream infection; SARS, severe acute respiratory syndrome; MDRAB, multi-drug-resistant *Acinetobacter baumannii*; XDRTB, extensively-drug-resistant tuberculosis; SNP, single nucleotide polymorphism; MDRGN, multi-drug-resistant Gram-negative bacteria; VRE, vancomycin-resistant enterococci; repPCR, repetitive element palindromic polymerase chain reaction; AP-PCR, arbitrarily primed polymerase chain reaction; RFLP, restriction fragment length polymorphism; AB, antibiotic; HCW, healthcare worker; IC, infection control.
